| Dr Lester K Leung, MD | |
|
520 Upper Chesapeake Dr, Suite 201, Bel Air, MD 21014-4339 | |
| (443) 643-3800 | |
| (433) 643-3856 |
| Full Name | Dr Lester K Leung |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 31 Years |
| Location | 520 Upper Chesapeake Dr, Bel Air, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851394126 | NPI | - | NPPES |
| 132203600 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | D0051209 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umd Upper Chesapeake Medical Center | Bel air, MD | Hospital |
| University Of Md Harford Memorial Hospital | Havre de grace, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upper Chesapeake Cardiology Associates Inc | 8325004047 | 10 |
| Upper Chesapeake Cardiology, Llc | 4183788847 | 11 |
News Archive
BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.
A new study suggests that people with muscle diseases such as muscular dystrophies may benefit more from group doctor visits than individual appointments. The study is published in the June 18, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.
NEBioCalculator, a new online "conversions and calculations" tool developed by New England Biolabs, offers bench-side support for molecular biology experimental planning.
For its 2010 second quarter, Ashland reported sales of $2,248 million, operating income of $151 million and net income of $22 million (27 cents per share). Net income was favorably affected by $2 million aftertax (2 cents per share) from discontinued operations. Cash flows provided by operating activities from continuing operations amounted to $183 million.
› Verified 2 days ago
| Entity Name | Upper Chesapeake Cardiology Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285771998 PECOS PAC ID: 8325004047 Enrollment ID: O20041204000256 |
News Archive
BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.
A new study suggests that people with muscle diseases such as muscular dystrophies may benefit more from group doctor visits than individual appointments. The study is published in the June 18, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.
NEBioCalculator, a new online "conversions and calculations" tool developed by New England Biolabs, offers bench-side support for molecular biology experimental planning.
For its 2010 second quarter, Ashland reported sales of $2,248 million, operating income of $151 million and net income of $22 million (27 cents per share). Net income was favorably affected by $2 million aftertax (2 cents per share) from discontinued operations. Cash flows provided by operating activities from continuing operations amounted to $183 million.
› Verified 2 days ago
| Entity Name | Upper Chesapeake Cardiology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851544159 PECOS PAC ID: 4183788847 Enrollment ID: O20090126000459 |
News Archive
BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.
A new study suggests that people with muscle diseases such as muscular dystrophies may benefit more from group doctor visits than individual appointments. The study is published in the June 18, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.
NEBioCalculator, a new online "conversions and calculations" tool developed by New England Biolabs, offers bench-side support for molecular biology experimental planning.
For its 2010 second quarter, Ashland reported sales of $2,248 million, operating income of $151 million and net income of $22 million (27 cents per share). Net income was favorably affected by $2 million aftertax (2 cents per share) from discontinued operations. Cash flows provided by operating activities from continuing operations amounted to $183 million.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lester K Leung, MD 520 Upper Chesapeake Dr, Suite 201, Bel Air, MD 21014-4339 Ph: (443) 643-3800 | Dr Lester K Leung, MD 520 Upper Chesapeake Dr, Suite 201, Bel Air, MD 21014-4339 Ph: (443) 643-3800 |
News Archive
BioControl Medical, a medical technology company that develops and markets advanced implantable devices for the treatment of autonomic disorders, has announced first patient enrollment in the INOVATE-HF (INcrease Of VAgal TonE in Heart Failure) clinical study at Northwest Texas Heart Hospital, Amarillo, Texas, by study investigator Suresh Neelagaru, M.D.
A new study suggests that people with muscle diseases such as muscular dystrophies may benefit more from group doctor visits than individual appointments. The study is published in the June 18, 2014, online issue of Neurology®, the medical journal of the American Academy of Neurology.
NEBioCalculator, a new online "conversions and calculations" tool developed by New England Biolabs, offers bench-side support for molecular biology experimental planning.
For its 2010 second quarter, Ashland reported sales of $2,248 million, operating income of $151 million and net income of $22 million (27 cents per share). Net income was favorably affected by $2 million aftertax (2 cents per share) from discontinued operations. Cash flows provided by operating activities from continuing operations amounted to $183 million.
› Verified 2 days ago
Nataliya Melnyk, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-3010 Fax: 443-643-3011 | |
Dr. Dhiraj Gurung, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-1000 | |
Qinglin Gao, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-1500 Fax: 443-643-1505 | |
Sudarshan Paudel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 520 Upper Chesapeake Dr Ste 201, Bel Air, MD 21014 Phone: 443-643-3800 | |
Dr. Kechi Amadi-obi, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-1500 Fax: 443-643-1505 | |
Frank Sparandero, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1032 Barrymore Dr, Bel Air, MD 21014 Phone: 908-938-1436 | |
Alan Sweatman, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 500 Upper Chesapeake Dr, Bel Air, MD 21014 Phone: 443-643-1000 |